Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 710 (USA) (Dr. Silva)
· consented 2012-10-02
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2012-10-04 (study day 3.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2012-10-04 (study day 3.0); relationship: REMOTE
moderate
assessed
2026-08-18
Moderate MYOCARDIAL INFARCTION — outcome: RECOVERED/RESOLVED; onset 2012-10-19 (study day 18.0); relationship: POSSIBLE; serious criteria: hospitalization
mild
assessed
2026-08-18
Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2012-10-14 (study day 13.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate SYNCOPE VASOVAGAL — outcome: RECOVERED/RESOLVED; onset 2012-10-19 (study day 18.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.